These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31064407)

  • 1. Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report.
    Garcia Casallas JC; Robayo-Amortegui H; Corredor-Rozo Z; Carrasco-Márquez AM; Escobar-Perez J
    J Med Case Rep; 2019 May; 13(1):141. PubMed ID: 31064407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.
    Cakirlar FK; Ciftci IH; Gonullu N
    Clin Lab; 2015; 61(7):741-7. PubMed ID: 26299073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data.
    Oikonomou O; Sarrou S; Papagiannitsis CC; Georgiadou S; Mantzarlis K; Zakynthinos E; Dalekos GN; Petinaki E
    BMC Infect Dis; 2015 Dec; 15():559. PubMed ID: 26653099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
    Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
    Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
    Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.
    Lowings M; Ehlers MM; Dreyer AW; Kock MM
    BMC Infect Dis; 2015 Nov; 15():521. PubMed ID: 26573617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
    J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteremia and meningitis caused by OXA-23-producing Acinetobacter baumannii - molecular characterization and susceptibility testing for alternative antibiotics.
    Schuertz KF; Tuon FF; Palmeiro JK; Conte D; Telles JPM; Trevisoli LE; Dalla-Costa LM
    Braz J Microbiol; 2018 Nov; 49 Suppl 1(Suppl 1):199-204. PubMed ID: 29720352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Epidemiology and Drug Resistance of Acinetobacter baumannii Isolated from Hospitals in Southern Poland: ICU as a Risk Factor for XDR Strains.
    Chmielarczyk A; Pilarczyk-Żurek M; Kamińska W; Pobiega M; Romaniszyn D; Ziółkowski G; Wójkowska-Mach J; Bulanda M
    Microb Drug Resist; 2016 Jun; 22(4):328-35. PubMed ID: 26745326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
    Çetinkol Y; Telli M; Altunçekiç Yıldırım A; Çalgın MK
    Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of children with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Vandepitte WP; Berge J; Andersson R
    J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S129-39. PubMed ID: 25509707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and molecular epidemiology of Acinetobacter baumannii bacteremia in neonates.
    Lee HY; Hsu SY; Hsu JF; Chen CL; Wang YH; Chiu CH
    J Microbiol Immunol Infect; 2018 Jun; 51(3):367-376. PubMed ID: 28830746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of colistin heteroresistance in Acinetobacter baumannii from blood and respiratory isolates.
    Srinivas P; Hunt LN; Pouch SM; Thomas K; Goff DA; Pancholi P; Balada-Llasat JM; Bauer KA
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):194-198. PubMed ID: 29482871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii ST2 Clinical Isolate in Algeria: First Case Report.
    Bakour S; Olaitan AO; Ammari H; Touati A; Saoudi S; Saoudi K; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):279-85. PubMed ID: 25588125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant Acinetobactor baumannii isolated from a traveler returned from Brunei.
    Tojo M; Mawatari M; Hayakawa K; Nagamatsu M; Shimada K; Mezaki K; Sugiki Y; Kuroda E; Takeshita N; Kutsuna S; Fujiya Y; Miyoshi-Akiyama T; Kirikae T; Ohmagari N
    J Infect Chemother; 2015 Mar; 21(3):212-4. PubMed ID: 25444675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.
    Agodi A; Voulgari E; Barchitta M; Quattrocchi A; Bellocchi P; Poulou A; Santangelo C; Castiglione G; Giaquinta L; Romeo MA; Vrioni G; Tsakris A
    J Hosp Infect; 2014 Apr; 86(4):260-6. PubMed ID: 24680473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.